Free Trial

Agile Therapeutics (AGRX) News Today

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)
Free AGRX Stock Alerts
$0.35
0.00 (0.00%)
(As of 06/14/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends
June 15 at 1:22 AM | americanbankingnews.com
Agile Therapeutics (NASDAQ:AGRX) Research Coverage Started at StockNews.com
June 7, 2024 | americanbankingnews.com
StockNews.com Begins Coverage on Agile Therapeutics (NASDAQ:AGRX)
May 16, 2024 | finanznachrichten.de
Agile Therapeutics, Inc.: Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 16, 2024 | investorplace.com
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
May 15, 2024 | sfgate.com
Agile Therapeutics: Q1 Earnings Snapshot
May 15, 2024 | finance.yahoo.com
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 | globenewswire.com
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
April 1, 2024 | finance.yahoo.com
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript
March 30, 2024 | seekingalpha.com
Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript
March 29, 2024 | investorplace.com
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 29, 2024 | finance.yahoo.com
Q4 2023 Agile Therapeutics Inc Earnings Call
March 28, 2024 | markets.businessinsider.com
Here's what to expect from Agile Therapeutics's earnings report
March 28, 2024 | finanznachrichten.de
Agile Therapeutics, Inc.: Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
March 28, 2024 | globenewswire.com
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
March 26, 2024 | msn.com
Why Agile Therapeutics (AGRX) Stock Is Down 60%
March 26, 2024 | finanznachrichten.de
Agile Therapeutics, Inc.: Agile Therapeutics Announces Delisting from Nasdaq
March 25, 2024 | globenewswire.com
Agile Therapeutics Announces Delisting from Nasdaq
March 23, 2024 | benzinga.com
Latest News for Agile Therapeutics Stock (NASDAQ:AGRX)
March 21, 2024 | markets.businessinsider.com
Agile Therapeutics is about to announce its earnings — here's what to expect
March 21, 2024 | benzinga.com
Agile Therapeutics's Earnings: A Preview
March 21, 2024 | globenewswire.com
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
March 20, 2024 | globenewswire.com
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
March 13, 2024 | msn.com
Agile Therapeutics stock soars on complete debt payoff
March 13, 2024 | globenewswire.com
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
February 24, 2024 | investing.com
Agile Therapeutics reduces warrant exercise price
February 22, 2024 | benzinga.com
Agile Therapeutics Stock (NASDAQ:AGRX), Short Interest Report
February 22, 2024 | benzinga.com
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
February 22, 2024 | finance.yahoo.com
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
February 22, 2024 | investorplace.com
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
February 22, 2024 | globenewswire.com
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
February 22, 2024 | investorplace.com
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
February 15, 2024 | msn.com
Agile Therapeutics reports higher prelim FY revenue than last year
February 15, 2024 | finance.yahoo.com
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
February 15, 2024 | globenewswire.com
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance Update
January 25, 2024 | markets.businessinsider.com
Buy Rating for Agile Therapeutics: Regulatory Tailwinds and Strong Sales Growth Forecast
January 23, 2024 | finance.yahoo.com
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
December 12, 2023 | finance.yahoo.com
Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement
November 23, 2023 | msn.com
Agile Therapeutics reports Q3 results
November 21, 2023 | benzinga.com
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
November 11, 2023 | markets.businessinsider.com
Agile Therapeutics: A Promising Investment with Positive Cash Flow Forecasts and Anticipated Growth in Twirla Sales
November 10, 2023 | finance.yahoo.com
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript
November 9, 2023 | finance.yahoo.com
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 8, 2023 | msn.com
Agile Therapeutics Q3 2023 Earnings Preview
October 26, 2023 | finance.yahoo.com
Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
October 5, 2023 | finanznachrichten.de
Agile Therapeutics, Inc.: Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
October 4, 2023 | finance.yahoo.com
Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2023 | finanznachrichten.de
Agile Therapeutics, Inc.: Agile Therapeutics Upgraded To "Buy" Rating By Analysts At Maxim Group
September 28, 2023 | finance.yahoo.com
Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group
September 27, 2023 | benzinga.com
Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group
September 5, 2023 | finance.yahoo.com
Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Get Agile Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter.

America's #1 AI Dividend Stock Revealed (Ad)

Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!

Click here now to claim your FREE copy of Marc's AI playbook.

AGRX Media Mentions By Week

AGRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGRX
News Sentiment
▼
0.00

0.89
▲
Average
Medical
News Sentiment

AGRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGRX Articles
This Week
▼
1

1
▲
AGRX Articles
Average Week

Get Agile Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AGRX) was last updated on 6/15/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...
Crypto 101 Media | Sponsored
Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does ...
Porter & Company | Sponsored
Tiny, One-Half Inch Pellet the Key to INFINITE Energy?
It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...
Eagle Publishing | Sponsored
Gold Set to EXPLODE!
The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...
Gold Safe Exchange | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored